Vivo Opportunity LLC 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 5:42 pm Sale | 2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Vivo Opportunity LLC | 2,251,663 3.600% | -149,613 (-6.23%) | Filing |
| 2022-02-11 5:21 pm Sale | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Vivo Opportunity LLC | 2,401,276 4.100% | -481,548 (-16.70%) | Filing |
| 2020-03-04 4:30 pm Purchase | 2020-02-25 | 13G | Avadel Pharmaceuticals plc AVDL | Vivo Opportunity LLC | 2,882,824 6.200% | 2,882,824 (New Position) | Filing |